Abstract: A fixation component includes tines extending from a base portion of the fixation component. Each tine is elastically deformable between a pre-set position and an open position. Each tine includes a hook segment extending from a proximal end near the base portion to a distal end. Each tine also includes a distal segment extending from the distal end of the hook segment to a tissue-piercing tip. When positioned in the pre-set position, the hook segment extends along a pre-set curvature that encloses an angle between 135 degrees and 270 degrees, and the distal segment extends away from a longitudinal axis of the fixation component.

Abstract: A cordless appliance includes a blender having a base unit with a housing and an upwardly opening upper cavity. A drive connection is positioned within the upwardly opening upper cavity. The housing further includes a battery-receiving cavity that is configured to receive a removable battery. A motor is disposed within the housing of the base unit it is contemplated to be powered by the removable battery. A blender jar includes an upper collar in an interior cavity. A first lid assembly is configured to be coupled to the upper collar of the blender jar and includes a blade assembly and a drive connecting member. A second lid assembly includes a cap member removably received on an open aperture of the second lid assembly. The first and second lid assemblies are configured for limited rotation with respect to the blender jar for engagement of the same.

Abstract: A vacuum cleaner assembly is provided that includes a body extending along an axis to a base connection end that includes a protrusion. A handle extends from the body opposite the base connection end. A dust collection portion includes a body connection end that includes a track with a lock passage extending perpendicularly from the track. The protrusion is located in the lock passage in a locked position and in the track in an unlocked position to selectively remove the dust collection portion from the body.

Abstract: A blade grinder that includes a base unit having a housing. The housing encloses a drive motor and defines a receiving cavity. A battery receiver is defined along a portion of the housing and a battery is removably coupled to the battery receiver. A blade implement is disposed within the receiving cavity, wherein the blade implement is configured to be driven by the drive motor. A bowl is positionable in an operably disposed condition within the receiving cavity. A lid is couplable to the housing to retain the bowl in the operably disposed condition within the receiving cavity.

Abstract: System and method for detecting the presence at a distance of materials utilizing the atomic structure and characteristics of the elements in the chemicals comprising the material.

Abstract: A method of treating a pulmonary disorder in a patient, comprising administering a pharmaceutical composition comprising an isotonic aqueous solution comprising a compound of formula I: or a pharmaceutically acceptable salt thereof, wherein the pulmonary disorder is asthma or chronic obstructive pulmonary disorder.

Abstract: The invention relates to a pharmaceutical composition comprising an isotonic aqueous solution comprising a compound of formula I: or a pharmaceutically acceptable salt thereof.

Abstract: System and method for detecting the presence at a distance of materials utilizing the atomic structure and characteristics of the elements in the chemicals comprising the material.

Abstract: The invention relates to a pharmaceutical composition comprising an isotonic aqueous solution comprising a compound of formula I: or a pharmaceutically acceptable salt thereof.

Abstract: The invention relates to a pharmaceutical composition comprising an isotonic aqueous solution comprising a compound of formula I: or a pharmaceutically acceptable salt thereof.

Abstract: The invention relates to a pharmaceutical composition comprising an isotonic aqueous solution comprising a compound of formula I: or a pharmaceutically acceptable salt thereof.

Abstract: The invention relates to a pharmaceutical composition comprising an isotonic aqueous solution comprising from about 0.05 ?g/mL to about 10 mg/mL of a compound of formula I: or a pharmaceutically acceptable salt thereof.

Abstract: The invention relates to a pharmaceutical composition comprising an isotonic aqueous solution comprising from about 0.05 ?g/mL to about 10 mg/mL of a compound of formula I: or a pharmaceutically acceptable salt thereof.

Abstract: The invention relates to a pharmaceutical composition comprising an isotonic aqueous solution comprising from about 0.05 ?g/mL to about 10 mg/mL of a compound of formula I: or a pharmaceutically acceptable salt thereof.

Abstract: A sealing assembly for sealing against a piece of oilfield equipment in a wellbore. The sealing assembly has a support housing and the support housing defines an inner wall and a port configured for fluid communication with the wellbore. Such inner wall defines a stop shoulder, and the support housing has a limit structure proximate one or both end(s). A sealing element is contained within the support housing. A ring is connected to the sealing element at one or both end(s). Each ring is configured for slidable movement along the inner wall of the support housing and further configured to float between the stop shoulder and the limit structure.

Abstract: This invention relates to a compound of formula I: or a pharmaceutically acceptable salt thereof. Such compounds possess both muscarinic receptor antagonist and ?2 adrenergic receptor agonist activities. The invention also relates to pharmaceutical compositions comprising such compounds, processes and intermediates for preparing such compounds, and methods of using such compounds as bronchodilating agents to treat pulmonary disorders.

Abstract: This invention relates to a compound of formula I: or a pharmaceutically acceptable salt thereof. Such compounds possess both muscarinic receptor antagonist and ?2 adrenergic receptor agonist activities. The invention also relates to pharmaceutical compositions comprising such compounds, processes and intermediates for preparing such compounds, and methods of using such compounds as bronchodilating agents to treat pulmonary disorders.

Abstract: This invention relates to a compound of formula I: or a pharmaceutically acceptable salt thereof. Such compounds possess both muscarinic receptor antagonist and ?2 adrenergic receptor agonist activities. The invention also relates to pharmaceutical compositions comprising such compounds, processes and intermediates for preparing such compounds, and methods of using such compounds as bronchodilating agents to treat pulmonary disorders.

Abstract: This invention relates to a compound of formula I: or a pharmaceutically acceptable salt thereof. Such compounds possess both muscarinic receptor antagonist and ?2 adrenergic receptor agonist activities. The invention also relates to pharmaceutical compositions comprising such compounds, processes and intermediates for preparing such compounds, and methods of using such compounds as bronchodilating agents to treat pulmonary disorders.

Abstract: This invention relates to a compound of formula I: or a pharmaceutically acceptable salt thereof. Such compounds possess both muscarinic receptor antagonist and ?2 adrenergic receptor agonist activities. The invention also relates to pharmaceutical compositions comprising such compounds, processes and intermediates for preparing such compounds, and methods of using such compounds as bronchodilating agents to treat pulmonary disorders.